European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
R A C HughesI N van Schaik

Abstract

Numerous sets of diagnostic criteria have sought to define chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and randomized trials and systematic reviews of treatment have been published. The objective is to prepare consensus guidelines on the definition, investigation and treatment of CIDP. Disease experts and a patient representative considered references retrieved from MEDLINE and Cochrane Systematic Reviews in May 2004 and prepared statements which were agreed in an iterative fashion. The Task Force agreed on good practice points to define clinical and electrophysiological diagnostic criteria for CIDP with or without concomitant diseases and investigations to be considered. The principal treatment recommendations were: (1) intravenous immunoglobulin (IVIg) or corticosteroids should be considered in sensory and motor CIDP (level B recommendation); (2) IVIg should be considered as the initial treatment in pure motor CIDP (Good Practice Point); (3) if IVIg and corticosteroids are ineffective plasma exchange (PE) should be considered (level A recommendation); (4) If the response is inadequate or the maintenance doses of the initial treatment are high, combination treatments or adding an immunosuppressant or immun...Continue Reading

References

Feb 20, 1986·The New England Journal of Medicine·P J DyckC Swanson
Jul 1, 1994·Journal of Neurology, Neurosurgery, and Psychiatry·M DonaghyJ Jacobs
Feb 27, 2001·Neurology·J R MendellUNKNOWN Working Group on Peripheral Neuropathy
Aug 17, 2001·Annals of Neurology·R HughesUNKNOWN Inflammatory Neuropathy Cause and Treatment (INCAT) Group
Nov 1, 2001·The Cochrane Database of Systematic Reviews·M M Mehndiratta, R A Hughes
Mar 1, 2002·The Cochrane Database of Systematic Reviews·M M Mehndiratta, R A Hughes
Dec 25, 2002·Neurology·Norman Latov
Apr 23, 2003·Neurology·J-M VallatP-M Preux
Mar 31, 2004·Muscle & Nerve·Peter Y K Van den Bergh, Françoise Piéret
Jul 22, 2004·The Cochrane Database of Systematic Reviews·M M MehndirattaP Agarwal
Sep 24, 2004·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M BraininUNKNOWN Guideline Standards Subcommittee of the EFNS Scientific Committee
Jun 6, 2007·Current Allergy and Asthma Reports·Man Mohan Mehndiratta, Avinash Chandra Singh

❮ Previous
Next ❯

Citations

Sep 20, 2008·Journal of Neurology·Richard Hughes
Nov 16, 2010·Journal of Neural Transmission·Dominik MadžarPiotr Lewczuk
Jan 16, 2007·Current Neurology and Neuroscience Reports·Thomas B Toothaker, Thomas H Brannagan
Apr 9, 2013·Current Treatment Options in Neurology·Mazen M Dimachkie, Richard J Barohn
Mar 6, 2009·Proceedings of the National Academy of Sciences of the United States of America·Björn TackenbergJan D Lünemann
Jan 5, 2013·Rheumatology·Raphaèle SerorUNKNOWN Club Rhumatismes et Inflammation Section of the SFR
Sep 18, 2008·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·I ElovaaraUNKNOWN EFNS
Aug 10, 2010·Journal of Inflammation·Natalia MossbergCharlotta Movitz
Jul 21, 2010·Neurology India·Kamakshi PatelSuraj Ashok Muley
Jun 26, 2012·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Bong-Hui KangKwang-Kuk Kim
Jan 27, 2012·Rinshō shinkeigaku = Clinical neurology·Masahiro Iijima
Mar 15, 2013·Practical Neurology·Kevin MoheePeter Goulding
Nov 3, 2006·Expert Review of Neurotherapeutics·Yee-Cheun Chan, Einar Wilder-Smith
Mar 19, 2008·Expert Review of Neurotherapeutics·H Franssen
Apr 15, 2008·Expert Opinion on Biological Therapy·F Eftimov, I N van Schaik
Feb 24, 2016·Annals of Clinical and Translational Neurology·Mark StettnerBernd C Kieseier
Aug 14, 2009·British Journal of Haematology·Jenny BirdUNKNOWN Haemato-oncology Task Force of the British Committee for Standards in Haematology, UK Myeloma Forum and Nordic Myeloma Study
Nov 18, 2008·Muscle & Nerve·Véronique BissayGuy Ebinger
Feb 5, 2009·Journal of the Peripheral Nervous System : JPNS·Sandrine LarueJean-Marc Léger
Jan 12, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A B BohnM E Hokland
Aug 9, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·D CocitoUNKNOWN Italian Network for CIDP Register
Apr 18, 2012·Acta Neurologica Scandinavica·N MossbergO Andersen
Jul 1, 2011·Journal of the Peripheral Nervous System : JPNS·Thomas H Brannagan
Sep 29, 2011·Acta Neurologica Scandinavica·A P VenizelosM A Fisher
Jun 22, 2010·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C PazzagliaL Padua
May 18, 2013·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M Mahdi-Rogers, R A C Hughes
Oct 30, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·D CocitoUNKNOWN Italian Network for CIDP Register

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.